{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"38"},{"groupId":"OG001","value":"41"}],"units":"Participants"}],"description":"Failure of intra-operative parathyroid hormone (PTH) to normalize (defined as failure of PTH to drop \\> 50% of its baseline value at final intra-operative PTH assay and/or failure of PTH to drop \\< 65 pg/ml or 6.9 pmol/L). Participants will be categorized as having persistent hyperparathyroidism (Immediate) Yes or No.","groups":[{"description":"For participants assigned to the study arm, the surgeon will use the PTeye as an intraoperative tool to identify if a suspect tissue is a parathyroid or not, during the parathyroid surgery.","id":"OG000","title":"Parathyroid Eye (PTeye)"},{"description":"The surgeon will proceed with the parathyroid surgery as usual, while relying solely on her/his surgical experience in identifying the parathyroid glands during the operations.","id":"OG001","title":"Usual Standard of Care"}],"paramType":"COUNT_OF_PARTICIPANTS","reportingStatus":"POSTED","timeFrame":"5-14 days after PTx procedure","title":"Number of Participants With Persistent Hyperparathyroidism (Immediate)","type":"SECONDARY","unitOfMeasure":"Participants"}